Vascular Solutions, Inc. v. Boston Scientific Corp.
This text of 562 F. App'x 967 (Vascular Solutions, Inc. v. Boston Scientific Corp.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
A preliminary injunction is a “drastic and extraordinary remedy that is not to be routinely granted.” Nat’l Steel Car, Ltd. v. Canadian Pac. Ry., Ltd., 357 F.3d 1319, 1324 (Fed.Cir.2004) (citing Intel Corp. v. VLSI Sys. Tech., Inc., 995 F.2d 1566, 1568 (Fed.Cir.1993)). As evidenced by the extended argument before this court, there are too many unresolved issues at this stage of the case and the record is too incomplete on issues of claim construction, infringement, and ultimate validity to warrant the grant of a preliminary injunction. For these reasons, we vacate the preliminary injunction.
VACATED
Each party shall bear its costs.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
562 F. App'x 967, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vascular-solutions-inc-v-boston-scientific-corp-cafc-2014.